Recent Finacing
Recent Raise
Sana develops cell therapies using in vivo gene delivery, ex vivo immune-evasive cell edits, and stem-cell-derived replacement cells, with R&D and manufacturing sites in Seattle, Cambridge, and South San Francisco.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Sana Biotechnology.
